Gastrointestinal tumor growth is thought to be promoted by gastrointestinal bacteria and their inflammatory products. We observed that intestine-specific conditional Apc mutant mice (FabplCre;Apc 15lox/+ ) developed many more colorectal tumors under conventional than under pathogen-low housing conditions. Shotgun metagenomic sequencing plus quantitative PCR analysis of feces DNA revealed the presence of two bacterial species in conventional mice, absent from pathogenlow mice. One, Helicobacter typhlonius, has not been associated with cancer in man, nor in immune-competent mice. The other species, mucin-degrading Akkermansia muciniphila, is abundantly present in healthy humans, but reduced in patients with inflammatory gastrointestinal diseases and in obese and type 2 diabetic mice. Eradication of H.typhlonius in young conventional mice by antibiotics decreased the number of intestinal tumors. Additional presence of A.muciniphila prior to the antibiotic treatment reduced the tumor number even further. Colonization of pathogen-low FabplCre;Apc 15lox/+ mice with H.typhlonius or A.muciniphila increased the number of intestinal tumors, the thickness of the intestinal mucus layer and A.muciniphila colonization without H.typhlonius increased the density of mucin-producing goblet cells. However, dual colonization with H.typhlonius and A.muciniphila significantly reduced the number of intestinal tumors, the mucus layer thickness and goblet cell density to that of control mice. By global microbiota composition analysis, we found a positive association of A.muciniphila, and of H.typhlonius, and a negative association of unclassified Clostridiales with increased tumor burden. We conclude that A.muciniphila and H.typhlonius can modulate gut microbiota composition and intestinal tumor development in mice.
Introduction
In the human intestine, the 10 14 microbial organisms (at least 160 species) normally participate in a symbiotic relationship with their host (1, 2) . Intestinal microbes protect against enteropathogens, extract nutrients and energy from diets and contribute to normal immune function (2) . Disruptions to the normal balance between the intestinal microbiota and the host can have detrimental effects on host physiology contributing to susceptibility for diseases such as obesity, fatty liver disease, type 1 and 2 diabetes and kidney disease (3) . Moreover, microbes in the gastrointestinal tract can promote tumor development. This is clearly illustrated by the fact that chronic gastritis due to Helicobacter pylori in the stomach increases the Downloaded from https://academic.oup.com/carcin/article-abstract/36/11/1388/370326 by guest on 07 February 2019 risk of sporadic gastric adenocarcinoma (4). Consequently, eradication of H.pylori by antibiotic treatment is regarded as a primary chemoprevention strategy to reduce gastric cancer incidence in man.
There is accumulating evidence that members of the gut microbiota are also involved in intestinal diseases such as inflammatory bowel disease, comprising both ulcerative colitis and Crohn's disease, and colorectal cancer (CRC) (5) . Because chronic inflammation represents a significant CRC risk factor, most studies focused on the small subset of colitis-associated colorectal cancers, and are based on mouse models. Colitis-prone mice, when treated with antibiotics or derived into germ-free conditions, were devoid of intestinal inflammation and colorectal tumors (6, 7) . More specifically, two human pathogens have been implicated in colitis-associated colorectal tumors, enterotoxigenic Bacteroides fragilis and Escherichia coli (8, 9) . The non-human enteric pathogens H.hepaticus and H.bilis can also induce colitisassociated colonic tumors in immunocompromised mice via upregulation of proinflammatory mediators (10) (11) (12) (13) (14) .
Intestinal microbiota may also influence the development of non-colitis-associated CRC. This was shown in Apc Min/+ mice, developing significantly fewer intestinal tumors under germ-free as compared to specific pathogen-free conditions (15) . This indicates that commensal bacteria are not required for, but can potentiate tumorigenesis independent of chronic inflammation. Recently, due to the development of unbiased high-throughput sequencing, details of the composition of the human CRC-associated microbiome are emerging (16) . Based on metagenomic analyses of CRC and adjacent normal tissues, overrepresentation of the periodontal pathogen Fusobacterium nucleatum in CRC was reported (17) (18) (19) . This species was recently shown to promote non-colitis-associated intestinal tumorigenesis in Apc Min/+ mice (20) .
Apc
Min/+ mice and other mouse models heterozygous for truncating mutant Apc alleles develop large numbers of intestinal tumors due to functional loss of the wild-type allele, thereby mimicking the hereditary colorectal tumor syndrome familial adenomatous polyposis. However, the murine tumors mainly occur in the small intestine. Our conditional Apc mutant FabplCre;Apc 15lox/+ mice, which are functionally wild-type for Apc in all cells except FabplCre-expressing epithelial cells of the distal small and large intestine develop tumors predominantly in the large intestine as in human familial adenomatous polyposis-related and sporadic colorectal cancer (21) . FabplCre;Apc 15lox/+ mice, like Apc Min/+ mice, develop non-colitis-associated intestinal tumors (11, 15, 20, 22) .
In this study, we investigated whether a decreased frequency of colon tumors in FabplCre;Apc 15lox/+ mice under pathogen-low housing conditions, as compared to conventional (i.e. pathogen higher) housing conditions, could be attributed to specific changes in intestinal microbial composition. We found two bacterial species, H.typhlonius and Akkermansia muciniphila, to be specifically associated with conventional housing. We tested their intestinal tumor-modulating role by eradicating them from conventional FabplCre;Apc 15lox/+ mice and by introducing them in pathogen-low FabplCre;Apc 15lox/+ mice.
Materials and methods

Bacterial strains and culturing
H.typhlonius (CCUG 48335T) was grown microaerobically (6% oxygen in a mixture of 10% carbon dioxide, 10% hydrogen and 80% nitrogen) on Biomerieux chocolate agar + PolyViteX (PVX) plates (Mediaproducts, Groningen, The Netherlands) for 2-3 days at 37°C (23, 24) . A.muciniphila MucT (ATTC BAA-835) was grown anaerobically in a basal mucin-based medium (25) .
Mice, cohousing, antibiotic treatment and oral gavage
All experiments on FabplCre;Apc 15lox/+ and Apc 15lox/+ mice in a C57BL/6 background were performed in accordance with institutional and national guidelines and regulations (21) . Treatment groups included equal numbers of males and females. Mice were housed under conventional conditions in open cages, or, after initial rederivation of the FabplCre and Apc 15lox/+ strains, under pathogen-low FELASA+ conditions in individually ventilated cages. Both conventional and pathogen-low mice received irradiated standard RM3 (P) food pellets (SDS, Essex, UK). Pathogen-low mice were provided with sterile water. The conventional condition was maintained through cohousing of conventional mice with newly generated pathogen-low mice in individually ventilated cages, resulting in cross-contamination by coprophagy, followed by generation of conventional offspring in individually ventilated cages.
For ablation of Helicobacter, an antibiotic cocktail of amoxicillin (600 mg/kg), metronidazole (200 mg/kg), and clarithromycin (100 mg/kg), combined with omeprazole (4 mg/kg) in standard food pellets was used (26) . In the colonization experiment, mice were pretreated with this antibiotic cocktail for 1 week at 3 weeks of age. Inoculations by oral gavages started 4 days later. Per gavage, 4 × 10 6 colony-forming units (cfus) H.typhlonius in 0.2 ml Brucella broth + 20% glycerol were administered, or 10 9 cfus A.muciniphila in 0.1 ml phosphate-buffered saline (PBS)-diluted anaerobic glycerol stock (27) . Bacterial colonization was validated in the feces by quantitative PCR (see below). Weight was measured every 2 weeks and feces samples were aseptically collected in liquid nitrogen and stored at −80°C until further processing.
Histological analysis
Tissues were fixed in 4% neutral buffered formalin, embedded in paraffin, sectioned and stained with H&E. Tumor numbers were based on tumors ≥1 mm. Histopathological analysis of the tumors was performed as described previously (21) . The degree of colitis was scored by one of the authors (D.S.), who was blinded to the genotype and experimental protocols used. Each of four histologic parameters were scored as absent (0), mild (1), moderate (2) or severe (3): mononuclear cell infiltraton, polymorphonuclear cell infiltration, epithelial hyperplasia and epithelial injury. A score ≥5 is indicative of colitis (6) .
Mucus layer thickness analysis and goblet cell counting
Colonic tissues were submerged in methanol-Carnoy's fixative (60% methanol, 30% chloroform, 10% glacial acetic acid) for 1 week. After processing and embedding in paraffin, 5 μm transverse sections were stained with alcian blue at pH 2.5 and periodic acid-Schiff (AB/PAS). Stained sections were scanned using the Philips Digital Pathology Solution (Philips, Best, The Netherlands). Digital images were analyzed with Image J (http:// imagej.nih.gov/ij/). The inner mucus layer thickness was measured perpendicular to this layer at 24 positions at equal distances starting from a randomly selected position per section per mouse without prior knowledge of the sample type. 
Fecal
Metagenomic sequencing and phylogenetic profiling
Genomic DNA libraries were prepared from 1 to 2 μg fecal DNA according to the Illumina protocol. Single-end shotgun metagenomic sequencing was performed using the Illumina Genome Analyzer I (Illumina, San Diego, CA) as described previously (28) . The pathogen-low sample consisted of 7 200 416 50-nucleotide reads and the conventional sample of 8 142 725 reads. Reads with undefined nucleotides were removed, resulting in 7 185 910 reads for the pathogen-low sample and 8 046 334 reads for the conventional sample. Reads were aligned to the non-redundant database (downloaded from https:/ www.ncbi.nlm.nih.gov/Ftp/ at the 31st of March 2010) with BLAST using BLASTx with the following parameters: blastall -p blastx -Q11 -a1 -F 'm S' -d nr -I <input> -m7 -<output> (29) . The BLASTx alignment results were loaded in MEGAN software (version 3.8) for taxonomy assignment, resulting in a file containing the taxonomy-assigned reads (30) . A hit should have a minimum blast score of 25 and only the top 20% hits with this score threshold was taken into account. A minimum of three hits was required to support an assignment to a given taxonomy node. Almost 21% of the reads of the conventional sample and 33% of the reads of the pathogen-low sample received taxonomic assignment. Cytoscape software (http://www.cytoscape.org/) was used to visualize the differences between taxonomy-assigned reads of both fecal DNA samples.
Quantitative polymerase chain reaction
Each quantitative polymerase chain reaction (qPCR) was performed in 10 μl according to standard procedures using 0.5 μl EvaGreen (Biotium, Hayward, CA), 0.5 unit FastStart Taq DNA polymerase (Roche Applied Science, Mannheim, Germany) and primer sets for H.typhlonius (forward 5′-AGGGACTCTTAAATATGCTCCTAGAGT-3′; reverse 5′-ATTCATCGTGTTTGAATGCGTCAA-3′, yielding a 123 bp product) and for A.muciniphila (forward 5′-CAGCACGTGAAGGTGGGGAC-3′; reverse 5′-CCTTGCGGTTGGCTTCAGAT-3′, yielding a 329 bp product) (31, 32) . Triplicate qPCR reactions were analyzed on the LightCycler 480 (Roche). Standard curves were created using serial 10-fold dilutions of H.typhlonius or A.muciniphila pure culture DNA corresponding to 10 ng/µl. The bacterial concentration of each sample was calculated by comparing the crossing point (Cp) values obtained from the standard curve. Definition of the upper limit for absence of the bacteria was based on qPCR data of a large series of fecal samples of pathogen-low mice in the breeding facility.
MITChip microarray analyses
The phylogenetic Mouse Intestinal Tract Chip (MITChip) microarray consists of 3580 different oligonucleotide probes that target the V1 and V6 hypervariable regions of the microbial 16S rRNA gene. MITChip analysis was performed as previously described (27, 33, 34) .
Statistical analyses
Generally, data were displayed in bar graph format, with the standard error of the mean (SEM) represented by the error bars. Data were significantly different according to post hoc ANOVA one-way statistical analysis, unless otherwise specified.
Results
Intestinal tumor number depends on housing conditions
We observed that FabplCre;Apc 15lox/+ mice, raised under new pathogen-low conditions, displayed a strongly reduced mean frequency of colorectal tumors (17%) in comparison to mice raised under old conventional housing conditions (63%) ( Figure 1A ). Such a reduction is potentially clinically relevant. Therefore, we established new 'conventional mice' by cohousing pathogen-low mice in individually ventilated cages in the new pathogen-low facility with mice that had been conventionally housed previously. We housed these new conventional and pathogen-low mice for 22 weeks under pathogen-low conditions. The pathogen-low FabplCre;Apc 15lox/+ mice displayed significantly fewer intestinal tumors (27%) as compared to the conventional mice (mean of 21.4 and 29.5, respectively, P < 0.01, Figure 1B ).
Conventional and pathogen-low mice differ in gut microbiome composition
We hypothesized that a housing-related difference in gut microbiota led to the reduced intestinal tumors in pathogen-low FabplCre;Apc 15lox/+ mice. To investigate this, feces of two conventional and two pathogen-low Apc 15lox/+ mice were commercially screened for the presence of bacterial pathogens. qPCR analysis indicated the presence in the conventional samples only of the species H.typhlonius, but not H.hepaticus or H.bilis (data not shown).
Since only pathogenic bacteria were included in the commercial screening, we performed shotgun metagenomic sequencing to compare the complete bacterial profiles of independent feces samples. Total DNA of a conventional and pathogen-low feces sample was used to generate, respectively, 5.0 and 9.4 Gb of sequence with the Genome Analyzer I (Illumina). Of the mapped reads, 392 548 (4.8% of total) and 391 717 (5.4% of total) could be assigned to bacterial sequences in the conventional and pathogen-low sample (Supplementary Table 1 , available at Carcinogenesis Online). Taxa were selected that showed at least a 20-fold difference in assigned reads between both samples and at least 1000 reads in either. Under these criteria, only taxa of the phyla Proteobacteria and Verrucomicrobia were overrepresented in the conventional sample (Figure 2A and Supplementary Table 1 , available at Carcinogenesis Online). Within Proteobacteria, the genus Helicobacter was responsible for the overrepresentation, in line with the commercial screening (Figure 2A and Supplementary  Table 1 , available at Carcinogenesis Online). Commercial, species-specific Helicobacter qPCR on both sequenced samples confirmed the earlier findings.
Within the phylum Verrucomicrobia, the genus Akkermansia was responsible for the overrepresentation in the conventional sample. This genus is known to have a single representative, A.muciniphila (Figure 2A and Supplementary Table 1, available at Carcinogenesis Online) (35, 36) .
To independently compare the global microbiota composition of the conventional and pathogen-low feces samples, we performed phylogenetic microarray analysis using the MITChip on four samples of each category (34) . Hierarchical cluster analysis demonstrated that the conventional and pathogen-low samples clustered separately ( Figure 2B ). Principal component analysis (PCA) revealed that members of unclassified Clostridiales correlated with pathogen-low housing. Among the taxa associated with conventional housing were A.muciniphila and Helicobacter ( Figure 2C ). qPCR of an extended series of conventional and pathogen-low samples revealed that, relative to pathogen-low mice, conventional mice showed on average a ~70 000-fold increase in H.typhlonius and a ~7000-fold increase in A.muciniphila ( Figure 2D ). Our data on the increased presence of H.typhlonius and A.muciniphila in conventional mice and the concomitant increase of intestinal tumors suggested that these two bacterial species were good candidates for microbiota-dependent intestinal tumor modulation.
Antibiotic treatment reduces intestinal tumor development
To investigate a potential relationship between the presence of H.typhlonius in the gut and intestinal tumor formation, the microbiota associated with the conventional condition was transferred to parental pathogen-low mice by 1 week of cohousing with conventional mice before breeding. Offspring mice were subdivided in three cohorts of both FabplCre;Apc 15lox/+ test and Apc 15lox/+ control mice. One cohort remained untreated [defined as normal food (NF) cohort]. The other two cohorts were treated with antibiotics (Abx: amoxicillin, metronidazole and clarithromycin, combined with omeprazole) in their food pellets to eradicate Helicobacter ( Figure 3A) . One of these was treated from 4 to 13 weeks of age (Abx pup cohort). In the other, treatment started already at embryonic day 11.5 via the pregnant mother, and continued up to 4 weeks of age (Abx embryo cohort). ( Figure 3B ). The average tumor area in both Abx cohorts was also reduced, but only significantly in the Abx pup cohort (P = 0.007) (Supplementary Figure 2A , available at Carcinogenesis Online).
Macroscopically, the tumor growth patterns of the antibiotictreated and untreated mice were similar and mainly sessile (79 and 89%; n = 84 and 80). Microscopically, the tumors of both antibiotic-treated and untreated mice were nearly all adenomas (100 and 96%, respectively) and mainly composed of tubular structures lined by dysplastic epithelium.
Next, we investigated the effect of the early presence of A.muciniphila in the gut on intestinal tumor formation, because we observed that only a subset of FabplCre; Apc 15lox/+ mice in the NF cohort and Abx pup cohort was positive for A.muciniphila (2/13 and 6/14, respectively) ( Figure 3C ). Apparently, although 1 week of cohousing was sufficient to transmit H.typhlonius from conventional to pathogen-low parental mice, transmission and establishment of A.muciniphila required a longer period of cohousing. In addition, we found that the antibiotic treatment eradicated not only H.typhlonius but also A.muciniphila (Supplementary Figure 1B, To investigate the effect of the antibiotic treatment on the global gut microbiota, we performed MITChip analysis on the feces of two mice of the NF cohort (those that were H.typhloniusand A.muciniphila-positive) and two of the Abx embryo cohort (that were H.typhlonius-and A.muciniphila-negative). Hierarchical cluster analysis demonstrated that the two types of samples clustered separately ( Figure 3E ). PCA showed that among the taxa that correlated with the antibiotic treatment, and therefore with reduced tumor numbers, were members of the order Clostridiales, including unclassified Clostridiales XIVa ( Figure 3F ).
Intestinal tumor modulation by colonization with H.typhlonius and/or A.muciniphila
To test whether colonization of H.typhlonius and/or A.muciniphila was associated with intestinal tumor modulation, we introduced these bacteria directly into the stomach Figure 3D , available at Carcinogenesis Online). Interestingly, this dual H.typhlonius/A.muciniphila cohort developed on average 14.8 intestinal tumors, comparable to the PBS cohort (P = 0.642) and significantly less than both the H.typhlonius (P = 0.043) and A.muciniphila cohorts (P = 0.002) ( Figure 4B ). The average tumor area was similar for all four cohorts (Supplementary Figure 4 , available at Carcinogenesis Online).
To investigate the effect of colonization of H.typhlonius and/or A.muciniphila on the global gut microbiota composition, we performed MITChip analysis of three mice in each cohort. Hierarchical clustering did not show a clear separation between the samples of the four cohorts (data not shown). However, the PCA revealed that the microbiota composition of the A.muciniphila and H.typhlonius cohorts separated from the H.typhlonius/A.muciniphila and PBS cohorts ( Figure 4C ). The taxa correlating with PBS and dual colonization, i.e. with reduced tumor numbers, contained Clostridiales, including unclassified Clostridiales XIVa and Bryantella et rel. (Figure 4C ).
The 15-27 tumors studied of each cohort were mainly adenomas (Supplementary Figure 5A -D, available at Carcinogenesis Online). The growth pattern was sessile, broad-based, pedunculated or polypoid. Most adenomas were histologically tubular with a large fraction composed of tubular structures lined by dysplastic epithelium. However, H.typhlonius, and/or A.muciniphila did not show colitis (histologic colitis score <1, see Supplementary Figure 5E , available at Carcinogenesis Online), indicating that colonization with these bacteria promoted noncolitis-associated tumorigenesis.
A.muciniphila has been shown to counteract the decreased thickness of the inner mucus layer in mice with high-fat dietinduced obesity (27) . To investigate the impact of A.muciniphila and H.typhlonius on mucus layer thickness, we established a new series of Apc 15lox/+ and FabplCre;Apc 15lox/+ mice, colonized these by triple gavages, and measured the inner mucus layer at 18-22 weeks (Figure 5A and C) . PBS-treated FabplCre;Apc 15lox/+ mice showed a thinner inner mucus layer than Apc 15lox/+ mice (12.3 ± 1.3 and 18.6 ± 3.4 µm, respectively), but this reduction was not significant (P = 0.074 by two-tailed Student t test). In FabplCre;Apc 15lox/+ mice, A.muciniphila significantly increased the thickness from 12.3 to 19.2 µm ( Figure 5A ). H.typhlonius also increased mucus layer thickness, but less than A.muciniphila (15.4 µm). Dual colonization resulted in a significantly thinner mucus layer (13.3 µm) than with A.muciniphila alone, and more comparable to the PBS cohort. Overall, the inner mucus layer in the FabplCre;Apc 15lox/+ cohorts followed the pattern of the average tumor count in these cohorts ( Figure 5A ).
Since mucus layer thickness is largely dependent on the number of mucus-producing goblet cells, we also investigated the goblet cell density (defined as the ratio between the goblet cell area and the mucosa area) in these mice. The FabplCre;Apc 
Discussion
This study was based on our observation that transfer of intestinal tumor-prone FabplCre;Apc 15lox/+ mice from conventional to pathogen-low housing conditions was accompanied by a significant decrease in the number of colorectal tumors. Considering that housing differences might change the mouse microbiota, we characterized these by metagenomic sequencing of the stool of mice kept under both conditions. These studies identified H.typhlonius and A.muciniphila as specifically associated with conventional housing. Our data corroborated the impact of different animal housing conditions on gut microbiota and on tumor load of Apc mutant mice (15, 37) .
We showed that H.typhlonius can act as a pathogen in immune-competent mice, because single H.typhlonius colonization of pathogen-low FabplCre;Apc 15lox/+ mice increased the number of intestinal tumors. Antibiotic eradication of H.typhlonius in conventionally housed mice reduced both tumor count and size, further supporting the pathogenic role of this species in intestinal tumor development. This tumor-promoting role in immune-competent mice is remarkable. H.typhlonius has been described as a pathobiont, a benign commensal in immunecompetent animals and only an opportunistic pathogen in immune-compromised Il10 −/− mice, where it causes severe typhlocolitis and colitis-associated neoplasia (24, 26) . Likewise, the closely related species H.hepaticus and H.bilis cause inflammation-mediated colon tumorigenesis in immune-compromised Rag2 −/− and Smad3 −/− mice (10) (11) (12) (13) (14) . Conflicting data exist with regard to the tumor-promoting role of Helicobacter infection in immune-competent Apc Min/+ mice. In one study, the combined infection of H.hepaticus and H.bilis did not result in the promotion of intestinal adenoma formation (11) . However, in another study an increase in intestinal adenoma multiplicity upon H.hepaticus infection was noted (12) . Our finding that H.typhlonius colonization of immune-competent FabplCre;Apc 15lox/+ mice increased the number of intestinal tumors is in accordance with the latter observation.
A.muciniphila is a mucin-degrading bacterium (25) . It is the single intestinal representative of the phylum Verrucomicrobia, and present at high numbers in the intestinal tract of healthy humans (abundance of 1-4% in colon). Its abundance inversely correlates with body weight, and the occurrence of several intestinal disorders including inflammatory bowel disease, diabetes, obesity, and appendicitis (36) . Recent studies showed a beneficial role of A.muciniphila. For instance, A.muciniphila treatment reversed highfat diet-induced metabolic disorders in mice, including adipose tissue inflammation and counteracted the diet-induced decrease in mucus layer and number of goblet cells (27, 38) . In another study, A.muciniphila colonization of gnotobiotic mice was shown to increase the number of mucus-producing goblet cells in cecum and colon (39) . On the other hand, A.muciniphila was increased in a T-cell transfer-mediated mouse model of intestinal inflammation, and decreased in Il10 −/− mice after colonization with the probiotic bacterium Enterococcus faecium NCIMB 10415, associated with reduced inflammation (40,41) . Moreover, A.muciniphila colonization of gnotobiotic mice exacerbated Salmonella thyphimurium-induced intestinal inflammation by its ability to disturb host mucus homeostasis (39) . This suggests that the role of A.muciniphila may be host-and condition-dependent.
Little is known about the relationship between A.muciniphila and intestinal cancer. A 4-fold higher abundance was found in the stool of CRC patients as compared to healthy subjects (42) . Akkermansia was likewise found to be significantly increased in mucosal biopsy samples of patients with colorectal adenomas (43) . However, several studies in man, mice and other model systems have shown that food intake reduction results in a significantly increased relative amount of A.muciniphila or related bacteria (44) . As it is known that CRC patients have a reduced food intake, meaningful interpretations of the intestinal microbiome associations await incorporation of dietary information in the analysis. In a mouse model of inflammation-associated CRC, enrichment for A.muciniphila genera was noted in the fecal content of tumor-bearing mice (45) . Recently, these authors reported that Akkermansia (together with members of Bacteroides) showed a positive correlation with increased inflammation-associated colonic tumor burden in contrast to members of Clostridiales, including multiple members of Clostridium group XIVa (46) . We note that, unlike our intervention studies, these findings may be reactive rather than causal. Our colonization experiments revealed a positive role for A.muciniphila and for H.typhlonius on tumor development of FabplCre;Apc 15lox/+ mice ( Figure 4A and B). Unsupervised cluster analysis by PCA demonstrated that multiple members of unclassified Clostridiales positively correlated with the H.typhlonius/A.muciniphila and control colonizations, i.e. with conditions of decreased tumor burden ( Figure 4C ). The positive association of A.muciniphila (and of H.typhlonius) and the negative association of unclassified Clostridiales with increased tumor burden was also apparent in the conventional-pathogen-low and NF-Abx embryo comparisons ( Figures 2C and 3F , respectively). Except for Bacteroidales, which did not emerge from our PCAs, these results are consistent with the recent findings in inflammation-associated CRC, showing that Akkermansia and Bacteroidales were correlated with exacerbated tumorigenesis and Clostridiales with tumor protection (46) .
The increased tumor count after colonization with A.muciniphila (and also with H.typhlonius) was accompanied by an increase of the mucus layer and goblet cell density. The latter effects of A.muciniphila were also reported by others for obese mice (27, 38) . However, although A.muciniphila counteracted the thinning of the mucus layer in both our tumor-prone mice and the described obese mice, it counteracted the obesity, while exacerbating the intestinal tumor phenotype. Thus, our data suggest that restoration by A.muciniphila of the thickness of the mucus layer (as a gut barrier) to normal levels in healthy mice, appears to aggravate the disease in tumor-prone mice. This unexpected phenomenon needs to be further investigated. Single colonization with H.typhlonius also caused a (non-significant) increase in mucus layer thickness in FabplCre;Apc 15lox/+ mice, but no increase in goblet cell density.
One would expect that co-colonization of both tumor-promoting bacterial species would lead to exacerbation, instead of the observed reduction, of intestinal tumor formation and to a further increase, instead of a decrease, in mucus layer thickness and goblet cell density. Apparently, A.muciniphila or H.typhlonius act differently upon joint colonization, indicative of a dualistic effect of these bacteria in concert with the host genetic background. In case of A.muciniphila, the possible dual effect on goblet cell density is reminiscent of recent findings in gnotobiotic mice, showing that A.muciniphila increased the number of goblet cells, but upon co-colonization exacerbated the decrease of goblet cell number by Salmonella thyphimurium (39) .
In conclusion, our work shows that A.muciniphila and H.typhlonius are prime candidates for microbiota-borne modulation of intestinal tumorigenesis, even while the complex antagonism and interaction with the host clearly needs further study. Investigation of the effect of A.muciniphila and/or H.typhlonius colonization on the gut immune system and permeability, and the metabolite production of the gut microbiota could prove valuable.
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